SCHEMBL8286097

SCHEMBL8286097

Cc1cc(N2CCN(CCN(C)C)CC2)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.45
HTR7 P34969 10/20 0.38
BRD1 O95696 1/20 0.37
TAF1 P21675 1/20 0.37
BRPF1 P55201 1/20 0.37
P2RY12 Q9H244 1/20 0.35
HTR2A P28223 5/20 0.35
HTR2C P28335 5/20 0.35
SLC6A4 P31645 5/20 0.35
HTR1A P08908 3/20 0.34
DRD2 P14416 3/20 0.34
DRD3 P35462 3/20 0.34
HTR6 P50406 3/20 0.34
DRD4 P21917 1/20 0.34
NCF1 P14598 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
GFER P55789 1/20 0.34
KCNH2 Q12809 2/20 0.34
HTR1D P28221 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286110 0.87 PDE11A (0.50) PDE11ALMNAPOLB
SCHEMBL8286107 0.87 PDE11A (0.54) PDE11ALMNAPOLBGFER
SCHEMBL8287402 0.84 PDE11A (0.39) PDE11AHTR7BRD1TAF1BRPF1
SCHEMBL8287827 0.84 PDE11A (0.51) PDE11ANCF1LMNAPOLB
SCHEMBL8287424 0.83 PDE11A (0.48) PDE11ALMNAPOLB
SCHEMBL8287829 0.82 PDE11A (0.64) PDE11ANCF1LMNAPOLB
SCHEMBL8287828 0.82 PDE11A (0.49) PDE11AHTR6NCF1POLB
SCHEMBL8286112 0.82 NCF1 (0.50) PDE11ANCF1LMNAPOLBGFER
SCHEMBL8286111 0.81 PDE11A (0.45) PDE11AP2RY12LMNAPOLB
SCHEMBL8287531 0.80 PDE11A (0.44) PDE11AHTR7HTR2AHTR2CHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed